Announced
Completed
Financials
Sources
Tags
France
Acquisition
Majority
Completed
Single Bidder
eye products
Pharmaceuticals
Domestic
Private
Friendly
Synopsis
BIOSYNEX, a biotechnology research company, completed the acquisition of eye care and ophthalmic business from Innoxa Laboratoires, a company specializing in the research, development and marketing of eye products. Financial terms were not disclosed. Through this acquisition, BIOSYNEX enters the eye comfort care market, the development of which is accelerating with the aging of the population (increased fragility of the eyes and ocular dryness), the growing exposure of the population to screens (computers and mobile phones).
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.